Osaka
Japan
Osaka International Cancer Institute
Non-small cell lung cancer, KRAS mutation, KRAS G12C, Next-generation sequencing, Tumor burden, PD-L1 expression
NSCLC, immunotherapy, EGFR-TKI, RMST, survival pattern